These pathways involve various intracellular messengers and enzymes, leading to changes in cellular activity
and awarded 40+ patents including the only patent in history on a nutrition program to enhance longevity and healthspan
Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback
Similarly, the functional precision plan may begin with early biochemical findings and subsequently be adjusted as genomic and metagenomic data are incorporated
M.RobertsR
This information may help provide context about your baseline metabolic sensitivity and which peptide formulation could be most compatible with your physiologythough genetic predisposition does not predict exact medication response
